AAAAAA
Results: 1-25/50
Authors:
BOWER M
ROYLANCE R
WAXMAN J
Citation: M. Bower et al., IMMUNOTHERAPY FOR RENAL-CELL CANCER, QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 91(9), 1998, pp. 597-602
Authors:
RUSTIN G
NEWLANDS E
BOWER M
Citation: G. Rustin et al., UNTITLED, International journal of gynecological cancer, 8(2), 1998, pp. 175-175
Authors:
FIFE K
BOWER M
COOPER RG
STEWART L
ETHERIDGE CJ
COOMBES RC
BULUWELA L
MILLER AD
Citation: K. Fife et al., ENDOTHELIAL-CELL TRANSFECTION WITH CATIONIC LIPOSOMES AND HERPES-SIMPLEX THYMIDINE KINASE MEDIATED KILLING, Gene therapy, 5(5), 1998, pp. 614-620
Authors:
BOWER M
RUSTIN GJS
NEWLANDS ES
HOLDEN L
SHORT D
FOSKETT M
BAGSHAWE KD
Citation: M. Bower et al., CHEMOTHERAPY FOR GESTATIONAL TROPHOBLASTIC TUMORS HASTENS MENOPAUSE BY 3 YEARS, European journal of cancer, 34(8), 1998, pp. 1204-1207
Authors:
BOWER M
BROCK C
BALESARIA S
NEWLANDS ES
FISHER RA
Citation: M. Bower et al., ALLELOTYPE ANALYSIS FOR LOSS OF CHROMOSOME-10 IN HIGH-GRADE GLIOMAS, Annals of oncology, 9, 1998, pp. 581-581
Authors:
WOOLAS RP
BOWER M
NEWLANDS ES
SECKL M
SHORT D
HOLDEN L
Citation: Rp. Woolas et al., INFLUENCE OF CHEMOTHERAPY FOR GESTATIONAL TROPHOBLASTIC DISEASE ON SUBSEQUENT PREGNANCY OUTCOME, British journal of obstetrics and gynaecology, 105(9), 1998, pp. 1032-1035
Authors:
NEWLANDS ES
BOWER M
HOLDEN L
SHORT D
SECKL MJ
RUSTIN GJS
BEGENT RHJ
BAGSHAWE KD
Citation: Es. Newlands et al., MANAGEMENT OF RESISTANT GESTATIONAL TROPHOBLASTIC TUMORS, Journal of reproductive medicine, 43(2), 1998, pp. 111-118
Authors:
NEWLANDS ES
BOWER M
FISHER RA
PARADINAS FJ
Citation: Es. Newlands et al., MANAGEMENT OF PLACENTAL SITE TROPHOBLASTIC TUMORS, Journal of reproductive medicine, 43(1), 1998, pp. 53-59
Authors:
NEWLANDS ES
BOWER M
HOLDEN L
SHORT D
BROCK C
RUSTIN GJS
BEGENT RHJ
BAGSHAWE KD
Citation: Es. Newlands et al., THE MANAGEMENT OF HIGH-RISK GESTATIONAL TROPHOBLASTIC TUMORS (GTT), International journal of gynaecology and obstetrics, 60, 1998, pp. 65-70
Authors:
BROCK CS
NEWLANDS ES
WEDGE SR
BOWER M
EVANS H
COLQUHOUN L
RODDIE M
GLASER M
BRAMPTON MH
RUSTIN GJS
Citation: Cs. Brock et al., PHASE-I TRIAL OF TEMOZOLOMIDE USING AN EXTENDED CONTINUOUS ORAL SCHEDULE, Cancer research, 58(19), 1998, pp. 4363-4367
Authors:
BOWER M
MA R
SAVAGE P
ABEL P
WAXMAN J
Citation: M. Bower et al., BRITISH UROLOGICAL SURGERY PRACTICE - 2 - RENAL, BLADDER AND TESTIS CANCER, British Journal of Urology, 81(4), 1998, pp. 513-517
Authors:
FIFE K
BULUWELA L
MILLER A
COOMBES RC
BOWER M
Citation: K. Fife et al., ANTI-ANGIOGENIC GENE-THERAPY, British Journal of Cancer, 78, 1998, pp. 52-52
Authors:
LYTTELTON MPA
NEWLANDS ES
GILES C
BOWER M
GUIMARAES A
OREILLY S
RUSTIN GJS
SAMSON D
KANFER EJ
Citation: Mpa. Lyttelton et al., HIGH-DOSE THERAPY INCLUDING CARBOPLATIN ADJUSTED FOR RENAL-FUNCTION IN PATIENTS WITH RELAPSED OR REFRACTORY GERM-CELL TUMOR - OUTCOME AND PROGNOSTIC FACTORS, British Journal of Cancer, 77(10), 1998, pp. 1672-1676
Authors:
DUNBRACK RL
GERLOFF DL
BOWER M
CHEN XW
LICHTARGE O
COHEN FE
Citation: Rl. Dunbrack et al., MEETING REVIEW - THE 2ND MEETING ON THE CRITICAL-ASSESSMENT OF TECHNIQUES FOR PROTEIN-STRUCTURE PREDICTION (CASP2), ASILOMAR, CALIFORNIA, DECEMBER 13-16, 1996, Folding & design, 2(2), 1997, pp. 27-42
Authors:
BROCK CS
BOWER M
Citation: Cs. Brock et M. Bower, CURRENT PERSPECTIVES IN GLIOMAS, Medical oncology, 14(2), 1997, pp. 103-120
Authors:
BOWER M
HOWARD M
GRACIE F
PHILLIPS R
FIFE K
Citation: M. Bower et al., A PHASE-II STUDY OF THALIDOMIDE FOR KAPOSIS-SARCOMA - ACTIVITY AND CORRELATION WITH KSHV DNA LOAD, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 76-76
Authors:
BOWER M
GOODCHILD K
EVANS H
NELSTROP A
RUSTIN GJS
Citation: M. Bower et al., FAFEC - A NOVEL REGIMEN FOR ADVANCED OVARIAN-CANCER, International journal of gynecological cancer, 7(1), 1997, pp. 14-17
Authors:
BOWER M
WAXMAN J
Citation: M. Bower et J. Waxman, GENE-THERAPY FOR PROSTATE-CANCER, Seminars in cancer biology, 8(1), 1997, pp. 3-9
Authors:
KYRITSIS A
NEWLANDS ES
BROCK CS
JAECKLE K
LEVIN V
BOWER M
EVANS H
DANE G
DEWITTE M
YUNG W
Citation: A. Kyritsis et al., PHASE-II TRIAL OF TOPOTECAN(T) AS A CONTINUOUS INTRAVENOUS-INFUSION IN PATIENTS (PTS) WITH HIGH-GRADE GLIOMAS, European journal of cancer, 33, 1997, pp. 917-917
Authors:
BOWER M
BROCK C
HOLDEN L
NELSTROP A
MAKEY AR
RUSTIN GJS
NEWLANDS ES
Citation: M. Bower et al., POMB ACE CHEMOTHERAPY FOR MEDIASTINAL GERM-CELL TUMORS/, European journal of cancer, 33(6), 1997, pp. 838-842
Authors:
BOWER M
FIFE K
LANDAU D
GRACIE F
PHILLIPS RH
GAZZARD BG
Citation: M. Bower et al., PHASE-II TRIAL OF 13-CIS-RETINOIC ACID FOR POOR-RISK HIV-ASSOCIATED KAPOSIS-SARCOMA, International journal of STD & AIDS, 8(8), 1997, pp. 518-521
Authors:
BOWER M
NEWLANDS ES
HOLDEN L
RUSTIN GJS
BEGENT RHJ
Citation: M. Bower et al., TREATMENT OF MEN WITH METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS WITH CYCLICAL POMB ACE CHEMOTHERAPY/, Annals of oncology, 8(5), 1997, pp. 477-483
Authors:
BOWER M
NEWLANDS ES
HOLDEN L
SHORT D
BROCK C
RUSTIN GJS
BEGENT RHJ
BAGSHAWE KD
Citation: M. Bower et al., EMA CO FOR HIGH-RISK GESTATIONAL TROPHOBLASTIC TUMORS - RESULTS FROM A COHORT OF 272 PATIENTS/, Journal of clinical oncology, 15(7), 1997, pp. 2636-2643
Authors:
DARK GG
BOWER M
NEWLANDS ES
PARADINAS F
RUSTIN GJS
Citation: Gg. Dark et al., SURVEILLANCE POLICY FOR STAGE-I OVARIAN GERM-CELL TUMORS, Journal of clinical oncology, 15(2), 1997, pp. 620-624
Authors:
BOWER M
NEWLANDS ES
BLEEHEN NM
BRADA M
BEGENT RJH
CALVERT H
COLQUHOUN I
LEWIS P
BRAMPTON MH
Citation: M. Bower et al., MULTICENTER CRC PHASE-II TRIAL OF TEMOZOLOMIDE IN RECURRENT OR PROGRESSIVE HIGH-GRADE GLIOMA, Cancer chemotherapy and pharmacology, 40(6), 1997, pp. 484-488